Shinsaku Kawaguchi Selected Research

apratoxin A

1/2020

Coibamide A Targets Sec61 to Prevent Biogenesis of Secretory and Membrane Proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinsaku Kawaguchi Research Topics

Disease

2	Neoplasms (Cancer) 01/2021 - 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

2	coibamide AIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
1	Lapatinib (GW572016)FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	SEC Translocation ChannelsIBA 01/2021
1	ipomoeassin FIBA 01/2020
1	apratoxin AIBA 01/2020